Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis

Overview of attention for article published in Frontiers in immunology, April 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 36,380 followers.

Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis https://t.co/QH7go0XzK3

17 May 2023

Reply Repost Favourite

RT @HudaHaq1: Only when you are reading about CAR-T cell therapy in r/r AML and come across a nice article. Give it a read, it’s worth it.…

17 May 2023

Reply Repost Favourite

Only when you are reading about CAR-T cell therapy in r/r AML and come across a nice article. Give it a read, it’s worth it. #hematology #pathology #oncology

17 May 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a…

25 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.